NDC 43093-101

Tabradol

Cyclobenzaprine Hydrochloride

Tabradol is a Oral Kit in the Human Prescription Drug category. It is labeled and distributed by Fusion Pharmaceuticals Llc. The primary component is .

Product ID43093-101_28c7b9e3-07ca-6f9b-e054-00144ff88e88
NDC43093-101
Product TypeHuman Prescription Drug
Proprietary NameTabradol
Generic NameCyclobenzaprine Hydrochloride
Dosage FormKit
Route of AdministrationORAL
Marketing Start Date2009-09-17
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameFusion Pharmaceuticals LLC
Active Ingredient Strength0
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 43093-101-01

1 KIT in 1 KIT (43093-101-01) * 125 mL in 1 BOTTLE, PLASTIC * 125 mL in 1 BOTTLE, PLASTIC * .25 g in 1 BOTTLE, GLASS
Marketing Start Date2009-09-17
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 43093-101-01 [43093010101]

Tabradol KIT
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2009-09-17
Inactivation Date2020-01-31

Drug Details

OpenFDA Data

SPL SET ID:5d19ef8b-eef3-4d52-95f5-929765ca6dc7
Manufacturer

NDC Crossover Matching brand name "Tabradol" or generic name "Cyclobenzaprine Hydrochloride"

NDCBrand NameGeneric Name
70332-106TabradolTabradol
43093-101TabradolTabradol
0093-1920Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
0093-1921Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
0093-3420Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
0093-3421Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
0093-3422Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
0115-1436Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
0115-1437Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
0179-0057cyclobenzaprine hydrochloridecyclobenzaprine hydrochloride
0179-0189cyclobenzaprine hydrochloridecyclobenzaprine hydrochloride
0378-0751Cyclobenzaprine Hydrochloridecyclobenzaprine hydrochloride
0378-0761Cyclobenzaprine Hydrochloridecyclobenzaprine hydrochloride
0378-0771Cyclobenzaprine Hydrochloridecyclobenzaprine hydrochloride
0440-1350Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
0440-7350Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
0591-3256Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
0591-3330Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
0591-5658Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
0615-3520Cyclobenzaprine Hydrochloridecyclobenzaprine hydrochloride
0615-7528Cyclobenzaprine Hydrochloridecyclobenzaprine hydrochloride
0615-8182Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
0904-7809Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride

Trademark Results [Tabradol]

Mark Image

Registration | Serial
Company
Trademark
Application Date
TABRADOL
TABRADOL
85002366 3980334 Dead/Cancelled
Fusion Pharmaceuticals
2010-03-30
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.